1. Home
  2. VSTM vs DH Comparison

VSTM vs DH Comparison

Compare VSTM & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • DH
  • Stock Information
  • Founded
  • VSTM 2010
  • DH 2011
  • Country
  • VSTM United States
  • DH United States
  • Employees
  • VSTM N/A
  • DH N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • DH Computer Software: Prepackaged Software
  • Sector
  • VSTM Health Care
  • DH Technology
  • Exchange
  • VSTM Nasdaq
  • DH Nasdaq
  • Market Cap
  • VSTM 313.1M
  • DH 310.5M
  • IPO Year
  • VSTM 2012
  • DH 2021
  • Fundamental
  • Price
  • VSTM $6.08
  • DH $2.92
  • Analyst Decision
  • VSTM Strong Buy
  • DH Hold
  • Analyst Count
  • VSTM 8
  • DH 11
  • Target Price
  • VSTM $13.00
  • DH $5.35
  • AVG Volume (30 Days)
  • VSTM 988.6K
  • DH 1.0M
  • Earning Date
  • VSTM 03-20-2025
  • DH 05-06-2025
  • Dividend Yield
  • VSTM N/A
  • DH N/A
  • EPS Growth
  • VSTM N/A
  • DH N/A
  • EPS
  • VSTM N/A
  • DH N/A
  • Revenue
  • VSTM $10,000,000.00
  • DH $252,202,000.00
  • Revenue This Year
  • VSTM N/A
  • DH N/A
  • Revenue Next Year
  • VSTM $867.23
  • DH $3.23
  • P/E Ratio
  • VSTM N/A
  • DH N/A
  • Revenue Growth
  • VSTM N/A
  • DH 0.31
  • 52 Week Low
  • VSTM $2.10
  • DH $2.55
  • 52 Week High
  • VSTM $13.52
  • DH $8.35
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 42.16
  • DH 36.61
  • Support Level
  • VSTM $6.01
  • DH $2.87
  • Resistance Level
  • VSTM $6.89
  • DH $3.07
  • Average True Range (ATR)
  • VSTM 0.47
  • DH 0.16
  • MACD
  • VSTM -0.14
  • DH 0.09
  • Stochastic Oscillator
  • VSTM 11.83
  • DH 69.23

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: